AVMA news
Drugs treating epilepsy, feline diabetes receive FDA approval
The Food and Drug Administration (FDA) has recently approved a number of animal drugs, including those that treat idiopathic epilepsy in dogs and…
AVMA news
Four veterinary scientists recognized with AVMA research awards
The AVMA honored Drs. Jim E. Riviere, Nicholas (Nick) Jeffery, Natasha Olby, and Boaz Arzi with 2023 AVMA Excellence Awards for contributions to…
AVMA news
FDA approves first animal drug for Giardia duodenalis, additional drugs for cows, swine
The Food and Drug Administration (FDA) has recently approved a number of animal drugs, including those that treat Giardia duodenalis in dogs.
AVMA news
New listings in AVMA Animal Health Studies Database – May 2023
The latest list of veterinary clinical studies in the AVMA Animal Health Studies Database (AAHSD) are available, including a study evaluating the…
AVMA news
AAHA publishes allergic skin disease guidelines for dogs, cats
On October 31, the American Animal Hospital Association (AAHA) announced the publication of the 2023 AAHA Management of Allergic Skin Diseases in Dogs…
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
AVMA news
North Carolina law will require veterinarians to report gabapentin use
As part of Governor Roy Cooper’s North Carolina Opioid Action Plan, a new law will require the state’s veterinarians to report the use of gabapentin…
AVMA news
Policies on physical restraint of animals, canine devocalization approved
The AVMA House of Delegates adopted a handful of revised animal welfare policies, including one on “Canine Devocalization” that supersedes the…
AVMA news
Generic drugs for treating inflammation, vomiting, parasites receive FDA approval
The Food and Drug Administration announced in March and April that it had approved six generic animal drugs.
AVMA news
Monoclonal antibodies show promise as new therapy for veterinary patients
More than 100 monoclonal antibodies (mAb) designed to bind to specific target proteins are available for humans, including those intended to treat…